Benzinga's Top #PreMarket Losers
December 04, 2014 at 08:25 AM EST
Kindred Biosciences (NASDAQ: KIN) shares dropped 25.32% to $6.90 in pre-market trading after the company reported that it has decided to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.